India’s indigenous COVID-19 Vaccine COVAXIN and the other vaccine Covishield got fresh orders from the Government of India. According to reports today, the centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of ₹ 205 and ₹ 215 per dose, respectively, excluding taxes, official sources said.
Reports coming in now states 37.5 crore of Covishield doses from the Serum Institute of India and 28.5 crore Covaxin doses from Bharat Biotech will be procured by December.
“An order to procure 66 crore more doses of COVID-19 vaccines–Covishield and Covaxin–to be supplied between August and December, at a revised price of ₹ 205 and ₹ 215 per dose, respectively, excluding taxes, has been placed,” the sources reportedly told Indian news agency PTI.
Although there is a decline in average daily new cases & active cases but we must remember that the pandemic is not yet over! There is no room for complacency. COVID Appropriate Behaviour must continue in line with the philosophy – Health Ministry said.
The price of each dose of Covishield amounts to ₹ 215.25 and Covaxin ₹ 225.75, including taxes, it said.
India administers 40 Crore COVAXIN and other vaccines till today
The Union health ministry which was procuring both the vaccines at ₹ 150 per dose, had indicated that the prices would be revised after the new COVID-19 vaccine procurement policy came into effect from June 21.
Under the new policy, the ministry will procure 75 per cent of the vaccines being produced by the drug manufacturers in the country.
COVID19 testing status update: According to @ICMRDELHI stated that 44,20,21,954 samples tested upto July 17, 2021 19,98,715 samples tested on July 17, 2021.